Founded in 2014, headquartered in Belgium, Xpress Biologics is a Biologics Contract Development and Manufacturing Organization (CDMO) providing development and manufacturing services of plasmid DNA (pDNA) and proteins to preclinical and clinical stage biotechnology companies and the co-development of novel therapeutics and vaccines. The company has a hybrid CDMO and co-development business model allowing for the development of new know-how, technology platforms, IP and a portfolio of co-proprietary molecules.